Jia Han

1.2k total citations
33 papers, 937 citations indexed

About

Jia Han is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jia Han has authored 33 papers receiving a total of 937 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Jia Han's work include MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (7 papers) and RNA modifications and cancer (5 papers). Jia Han is often cited by papers focused on MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (7 papers) and RNA modifications and cancer (5 papers). Jia Han collaborates with scholars based in China, Japan and United States. Jia Han's co-authors include Ni Hou, Yan Yuan, Chen Huang, Na Liu, Jie Li, Xiaofei Wang, Jiangli Pang, Dongdong Tong, Chun Chang Huang and Zhihai Tan and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and The Journal of the Acoustical Society of America.

In The Last Decade

Jia Han

32 papers receiving 925 citations

Peers

Jia Han
Jeong‐Eun Lee South Korea
Jorge Ernesto González Mesa Cuba
Wenhua Jiang China
Wenfang Chen China
V. Venkateswaran Canada
Zhanggui Wang China
Robert M Flight United States
Hiroko Kato Solvang Norway
Huihan Wang China
Jinye Zhang China
Jeong‐Eun Lee South Korea
Jia Han
Citations per year, relative to Jia Han Jia Han (= 1×) peers Jeong‐Eun Lee

Countries citing papers authored by Jia Han

Since Specialization
Citations

This map shows the geographic impact of Jia Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jia Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jia Han more than expected).

Fields of papers citing papers by Jia Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jia Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jia Han. The network helps show where Jia Han may publish in the future.

Co-authorship network of co-authors of Jia Han

This figure shows the co-authorship network connecting the top 25 collaborators of Jia Han. A scholar is included among the top collaborators of Jia Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jia Han. Jia Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Man, Wei Luo, Jia Han, et al.. (2025). An injectable hyaluronic acid–silanol hydrogel containing arginine and puerarin for immune modulation and enhanced diabetic wound healing. Bioactive Materials. 54. 850–870. 1 indexed citations
2.
Han, Jia, Takeru Oyama, Emi Morioka, et al.. (2024). Periarterial or perivenous invasion is an independent indicator of lymph node metastasis in invasive breast carcinoma of no special type. Pathology - Research and Practice. 260. 155407–155407. 1 indexed citations
3.
Han, Jia, et al.. (2024). The Progress and Prospects of Immune Cell Therapy for the Treatment of Cancer. Cell Transplantation. 33. 4241289748–4241289748. 26 indexed citations
4.
Watanabe, Takuya, et al.. (2023). Glioblastoma/high-grade glioma with a primitive neuronal component including rhabdoid differentiation that was difficult to diagnose: A case report. Pathology - Research and Practice. 251. 154830–154830. 1 indexed citations
5.
6.
Han, Jia, et al.. (2020). Efficacy and Prognostic Factors for PARP Inhibitors in Patients With Ovarian Cancer. Frontiers in Oncology. 10. 958–958. 15 indexed citations
7.
Han, Jia, Ruili Ma, Huahua Zhang, et al.. (2020). Norepinephrine‐CREB1‐miR‐373 axis promotes progression of colon cancer. Molecular Oncology. 14(5). 1059–1073. 25 indexed citations
8.
Tan, Xiaoyan, et al.. (2019). A mitochondria-targeted delivery system of doxorubicin and evodiamine for the treatment of metastatic breast cancer. RSC Advances. 9(63). 37067–37078. 17 indexed citations
9.
Sodhi, Chhinder P., Lysandra Voltaggio, Xirui Hou, et al.. (2019). The recruitment of extra-intestinal cells to the injured mucosa promotes healing in radiation enteritis and chemical colitis in a mouse parabiosis model. Mucosal Immunology. 12(2). 503–517. 8 indexed citations
10.
Yuan, Xiaoshuai, Feichao Bao, Wang Lv, et al.. (2019). Downregulation of HSPA2 inhibits proliferation via ERK1/2 pathway and endoplasmic reticular stress in lung adenocarcinoma. Annals of Translational Medicine. 7(20). 540–540. 18 indexed citations
11.
Hu, Xiaoyi, Jiyu Miao, Min Zhang, et al.. (2018). miRNA-103a-3p Promotes Human Gastric Cancer Cell Proliferation by Targeting and Suppressing ATF7 in vitro.. PubMed. 41(5). 390–400. 58 indexed citations
12.
Han, Jia, Jie Li, Huahua Zhang, et al.. (2017). miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin. Experimental Cell Research. 360(2). 328–336. 49 indexed citations
13.
Yang, Yang, Zhenghao Zhao, Ni Hou, et al.. (2017). MicroRNA-214 targets Wnt3a to suppress liver cancer cell proliferation. Molecular Medicine Reports. 16(5). 6920–6927. 17 indexed citations
14.
Zhao, Lingyu, Yingxun Liu, Dongdong Tong, et al.. (2017). MeCP2 Promotes Gastric Cancer Progression Through Regulating FOXF1/Wnt5a/β-Catenin and MYOD1/Caspase-3 Signaling Pathways. EBioMedicine. 16. 87–100. 66 indexed citations
15.
Liu, Na, Zhenghao Zhao, Jia Han, et al.. (2016). MicroRNA-302a enhances 5-fluorouracil-induced cell death in human colon cancer cells. Oncology Reports. 37(1). 631–639. 30 indexed citations
16.
17.
Zhao, Ling, Yu Yao, Jia Han, et al.. (2014). miR-638 Suppresses Cell Proliferation in Gastric Cancer by Targeting Sp2. Digestive Diseases and Sciences. 59(8). 1743–1753. 61 indexed citations
18.
Hou, Ni, Jia Han, Jie Li, et al.. (2014). MicroRNA Profiling in Human Colon Cancer Cells during 5-Fluorouracil-Induced Autophagy. PLoS ONE. 9(12). e114779–e114779. 23 indexed citations
19.
Ding, Ying, Min Song, Jia Han, et al.. (2013). Entitymetrics: Measuring the Impact of Entities. PLoS ONE. 8(8). e71416–e71416. 70 indexed citations
20.
Huang, Chun Chang, et al.. (2006). Charcoal records of fire history in the Holocene loess–soil sequences over the southern Loess Plateau of China. Palaeogeography Palaeoclimatology Palaeoecology. 239(1-2). 28–44. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeong‐Eun Lee Breakdown of academic impact, for papers by Jorge Ernesto González Mesa Breakdown of academic impact, for papers by Wenhua Jiang Breakdown of academic impact, for papers by Wenfang Chen Breakdown of academic impact, for papers by V. Venkateswaran Breakdown of academic impact, for papers by Zhanggui Wang Breakdown of academic impact, for papers by Robert M Flight Breakdown of academic impact, for papers by Hiroko Kato Solvang Breakdown of academic impact, for papers by Huihan Wang Breakdown of academic impact, for papers by Jinye Zhang
Rankless by CCL
2026